Table 3

Evaluation for PAS and association with immunoreactivity for p63, α-SMA, E-cadherin and Ki-67 in groups
Score Areas
In situ Invasive
Group 1 Group 2 Group 1 Group 2
p63 0 0/20 1/21 12/21 13/21
1 0/20 3/21 6/21 5/21
2 7/20 6/21 3/21 3/21
3 13/20 11/21 0/21 0/21
α-SMA 0 1/20 6/21 13/21 14/21
1 5/20 5/21 8/21 6/21
2 4/20 3/21 0/21 1/21
3 10/20 7/21 0/21 0/21
E-cadherin 0 0/24 0/24 17/25 15/24
1 3/24 7/24 8/25 9/24
2 21/24 17/24 0/25 0/24
Ki-67 (Mean value) 5.6 (22) 8.7 (22) 5.62 (22) 12 (22)

Group 1, represented by cases with low versican expression; and Group 2, represented by cases with versican overexpression.

Significant differences at P < 0.0001 between in situ and invasive areas in p63, α-SMA, and e-cadherin using the Wilcoxon Test.

Damasceno et al.

Damasceno et al. BMC Veterinary Research 2012 8:195   doi:10.1186/1746-6148-8-195

Open Data